Infectious disease · Phase III

Top sponsors

• United Therapeutics Europe 22 programs
• GSK Glaxo Smith 20 programs
• BRIGHT MINDS BIOSCIENCES 18 programs
• Chinese Academy of 13 programs
• Takeda 12 programs
• Sinovac Research and 11 programs
• Gilead Sciences Ireland 10 programs
• PARItec 10 programs
• Gilead Sciences 9 programs
• Pfizer 8 programs
• Vir Biotechnology 7 programs
• George Institute for 6 programs

1. Placebo

   GlaxoSmithKline

   Infections, Papillomavirus

   phase 3 · mab · completed

   1 trial →

2. Placebo capsules for bacterial sexually transmitted…

   The George Institute

   bacterial sexually transmitted infections

   phase 3 · small molecule · active

   1 trial →

3. Placebo for Bepirovirsen Solution for Injection 150 mg/mL

   GlaxoSmithKline

   Hepatitis B, Chronic

   phase 3 · small molecule · active

   1 trial →

4. Placebo for Bepirovirsen Solution for Injection 150 mg/mL

   GlaxoSmithKline

   Hepatitis B, Chronic

   phase 3 · small molecule · active

   1 trial →

5. Prevnar 13™

   Merck KGaA, Darmstadt, Germany

   Pneumococcal Infections

   phase 3 · mab · completed

   1 trial →

6. RC 4/24 TREAT-UTI

   Istituto Gentili S.r.l.

   Urinary Tract Infections

   phase 3 · small molecule · active

   1 trial →

7. RESPIRATORY SYNCYTIAL VIRUS VACCINES

   The George Institute

   RSV infection

   phase 3 · small molecule · active

   1 trial →

8. RHB-105

   RedHill Biopharma

   Helicobacter Pylori Infection

   phase 3 · small molecule · completed

   1 trial →

9. RHB-204

   RedHill Biopharma

   Pulmonary Mycobacterium Avium Complex Infection

   phase 3 · small molecule · terminated

   1 trial →

10. RIPH_2019_01

    Tour Hekla

    Adult with an staphylococcal prosthetic joint infection treated with debridement, antibiotics and implant retention (DAIR strategy)

    phase 3 · small molecule · active

    1 trial →

11. RO7496998

    Atea Pharmaceuticals

    COVID-19

    phase 3 · small molecule · terminated

    1 trial →

12. RSV MAT

    GlaxoSmithKline

    Respiratory Syncytial Virus Infections

    phase 3 · mab · terminated

    1 trial →

13. RSVpreF

    Pfizer

    Respiratory Tract Infection

    phase 3 · mab · completed

    1 trial →

14. Recombinant 14-Valent Human Papillomavirus Vaccine（Insect Cell）

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HPV InfectioN

    phase 3 · mab · active

    1 trial →

15. Recombinant SARS-CoV-2 fusion protein vaccine (V-01)

    Livzon Pharmaceutical Group

    COVID-19 Pandemic

    phase 3 · mab · active

    1 trial →

16. Recommended treatment schedule

    Prime Medicine

    COVID-19

    phase 3 · small molecule · terminated

    1 trial →

17. Remdesivir

    The First People's Hospital of Lianyungang

    Covid19

    phase 3 · small molecule · active

    1 trial →

18. Resatorvid

    Takeda

    Sepsis

    phase 3 · small molecule · completed

    2 trials →

19. Ribavirin

    Vertex Pharmaceuticals (Australia) Pty.

    Genotype 1 Chronic Hepatitis C

    phase 3 · small molecule · completed

    1 trial →

20. Ridinilazole

    Summit Therapeutics

    Clostridioides Difficile Infection

    phase 3 · small molecule · completed

    2 trials →

21. Rukobia 600 mg prolonged-release tablets

    ViiV Healthcare Pty Ltd

    Heavily Treatment Experienced Subjects Infected with Multi-drug Resistant (MDR) HIV-1

    phase 3 · small molecule · active

    1 trial →

22. S-217622

    Shionogi B.V.

    SARS-CoV-2 Infection

    phase 3 · small molecule · completed

    1 trial →

23. SARS-CoV-2 Vaccine (Vero Cell), Inactivated

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19 Pneumonia

    phase 3 · mab · completed

    1 trial →

24. SARS-CoV-2 inactivated vaccine

    Sinovac Research and Development Co.,

    Covid19

    phase 3 · mab · completed

    1 trial →

25. SARS-CoV-2 mRNA Vaccine

    Biotech Pharmaceutical Co.,

    COVID-19

    phase 3 · mab · active

    1 trial →

26. SARS-CoV-2 vaccine (inactivated)

    Sinovac Research and Development Co.,

    SARS-CoV2 Infection

    phase 3 · mab · completed

    1 trial →

27. SER-109

    Seres Therapeutics

    Clostridium Difficile Infection

    phase 3 · mab · completed

    1 trial →

28. SER-109

    Seres Therapeutics

    Clostridioides Difficile Infection

    phase 3 · mab · completed

    1 trial →

29. SHP640

    Takeda

    Adenoviral Conjunctivitis

    phase 3 · small molecule · terminated

    2 trials →

30. SHP640

    Takeda

    Bacterial Conjunctivitis

    phase 3 · small molecule · completed

    1 trial →

31. SOC plus 15mg/kg EB05 IV

    Edesa Biotech

    COVID-19

    phase 3 · mab · on hold

    1 trial →

32. SOF

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic HCV Infection

    phase 3 · small molecule · completed

    2 trials →

33. SOF/VEL

    Gilead Sciences Ireland UC

    Hepatitis C Virus Infection

    phase 3 · small molecule · completed

    3 trials →

34. SOF/VEL/VOX

    Gilead Sciences Ireland UC

    Hepatitis C Virus Infection

    phase 3 · small molecule · completed

    1 trial →

35. SPR994-305

    Spero Therapeutics

    complicated urinary tract infection (cUTI) or acute pyelonephritis (AP)

    phase 3 · small molecule · active

    1 trial →

36. Sarilumab

    Regeneron UK Limited

    COVID-19

    phase 3 · small molecule · completed

    1 trial →

37. Sarilumab SAR153191

    Regeneron UK Limited

    Corona Virus Infection

    phase 3 · small molecule · completed

    1 trial →

38. Sinovac PCV13

    Sinovac Research and Development Co.,

    Pneumococcal Infectious Diseases

    phase 3 · mab · active

    1 trial →

39. Sinovac PCV13

    Sinovac Research and Development Co.,

    Pneumococcal Infectious Disease

    phase 3 · mab · active

    2 trials →

40. Sofosbuvir

    Gilead Sciences Ireland UC

    Hepatitis C

    phase 3 · small molecule · completed

    2 trials →

41. Sofosbuvir

    Gilead Sciences Ireland UC

    Chronic HCV Infection

    phase 3 · small molecule · completed

    1 trial →

42. Standard Care

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 3 · other · completed

    1 trial →

43. Standard of Care PO (oral) antibiotics

    United Therapeutics Europe Ltd

    Infections

    phase 3 · small molecule · active

    1 trial →

44. Sulopenem

    Iterum Therapeutics plc

    Complicated Urinary Tract Infections

    phase 3 · small molecule · completed

    1 trial →

45. Sulopenem etzadroxil/probenecid

    Iterum Therapeutics plc

    Urinary Tract Infections

    phase 3 · small molecule · completed

    1 trial →

46. Sulopenem-Etzadroxil/Probenecid

    Iterum Therapeutics plc

    Uncomplicated Urinary Tract Infections

    phase 3 · small molecule · completed

    1 trial →

47. Suptavumab 30 mg/kg

    Regeneron UK Limited

    Respiratory Syncytial Virus Infections

    phase 3 · small molecule · completed

    1 trial →

48. TAK-019

    Takeda

    Coronavirus Disease (COVID-19)

    phase 3 · mab · completed

    1 trial →

Frequently asked questions